Bio-REGNET Developing an Ontology for the U.S. Patent System Siddharth Taduri, Hang Yu, Gloria T. Lau, Kincho H. Law, Jay P. Kesan Stanford University University of Illinois Urbana-Champaign 06/13/2011
Feb 14, 2016
Bio-REGNETDeveloping an Ontology for the U.S. Patent System
Siddharth Taduri, Hang Yu, Gloria T. Lau, Kincho H. Law, Jay P. KesanStanford UniversityUniversity of Illinois Urbana-Champaign06/13/2011
Problem Statement
• Patent Validity and Enforcement Questions involves analysis of documents in various domains – World-wide Patents, PTO File Wrappers, Scientific Publications and Court documents
• The information is siloed into several diverse information sources
06/13/2011 2
Issued Patents
and Applicatio
nsCourt Cases
File Wrappers
Technical Publicatio
nsRegulations and Laws
•The sources are diverse in structure, formats, semantics and syntax
• How to develop a comprehensive knowledge of patents in a particular technological space?
Problem StatementIssued Patents
and Applicatio
nsCourt Cases
File Wrappers
Technical Publicatio
nsRegulations and Laws
Specific Technical Domain
06/13/2011 3
Patents Documents
Over 7 million U.S. patents
In 2009, 485,312 patent applications were filed
Information is contained in various sections of the documents; a full-text search alone is not sufficient – other metrics such as classification, citations etc. need to be considered
Documents are available in HTML Format and can be easily parsed
06/13/2011 4
Court Cases
Court Cases are not very well structured!
Comparatively more difficult to parse information
PACER – an electronic system to access databases for U.S. Courts - requires one to know party/assignee name, case number/type, etc. which may not be known
927 F.2d 1200 (1991)
AMGEN, INC., Plaintiff/Cross-Appellant,v.
CHUGAI PHARMACEUTICAL CO., LTD., and Genetics Institute, Inc., Defendants-Appellants.
Nos. 90-1273, 90-1275.United States Court of Appeals, Federal Circuit.
March 5, 1991.
Suggestion for Rehearing Declined May 20, 1991.… …
Before MARKEY, LOURIE and CLEVENGER, Circuit Judges.…THE PATENTSOn June 30, 1987, the United States Patent and Trademark Office (PTO) issued to Dr. Rodney Hewick U.S. Patent 4,677,195, entitled "Method for the Purification of Erythropoietin and Erythropoietin Compositions" (the '195 patent). The patent claims both homogeneous EPO and compositions thereof and a method for purifying human EPO using reverse phase high performance liquid chromatography. The method claims are not before us. The relevant claims of the '195 patent are:1. Homogeneous erythropoietin characterized by a molecular weight of about 34,000
daltons on SDS PAGE, movement as a single peak on reverse phase high performance liquid chromatography and a specific activity of at least 160,000 IU per absorbance unit at 280 nanometers.
* * * * * *3. A pharmaceutical composition for the treatment of anemia comprising a therapeutically
effective amount of the homogeneous erythropoietin of claim 1 in a pharmaceutically acceptable vehicle.
4. Homogeneous erythropoietin characterized by a molecular weight of about 34,000 daltons on SDS PAGE, movement as a single peak on reverse phase high performance liquid chromatography and a specific activity of at least about 160,000 IU per absorbance unit at 280 nanometers.
06/13/2011 5
Patent File Wrappers File Wrappers are folders which contain all documents exchanged between a patent applicant and the patent office
Every File Wrapper is different! No standardized ordering of events
The relevant information is embed within lots of irrelevant text
File Wrappers are available as images requiring additional processing in order to extract text
Events Text
06/13/2011 6
There are many aspects of these documents which can be utilized; especially the cross-referencing between the documents
PATENT
United States Patent, 5,955,422September 21, 1999
Production of erthropoietin
Abstract: Disclosed are novel polypeptides possessing part or all of the primary structural conformation and one or more of the biological properties of mammalian erythropoietin ("EPO") …
Inventors: Lin; Fu-Kuen (Thousand Oaks, CA)Assignee: Kirin-Amgen, Inc. (Thousand Oaks, CA) Appl. No.: 08/100,197Filed: August 2, 1993.
COURT CASE
314 F.3d 1313 (2003)AMGEN INC., Plaintiff-Cross Appellant v. HOECHST MARION ROUSSEL, INC. (now known as Aventis Pharmaceuticals, Inc.) and Transkaryotic Therapies, Inc., Defendants-Appellants.
…Plaintiff-Cross Appellant Amgen Inc. is the owner of numerous patents directed to the production of erythropoietin ("EPO"), …alleging that TKT's Investigational New Drug Application ("INDA") infringed United States Patent Nos. 5,547,933; 5,618,698; and 5,621,080. The complaint was amended in October 1999 to include United States Patent Nos. 5,756,349 and 5,955,422, which issued after suit was filed.
FILE WRAPPERU.S. Patent 5,955,422
…
Claims 61-63 are rejected under 35 U.S.C. § 103 as being unpatentable over any one of Miyake et al., 1977 (R)
…In accordance with the provisions of 37 C.F.R. §1.607, the present continuation is being filed for the purpose of
…
Publication Database
REGULATIONS:U.S. Code Title 35, C. F. R Title 37, M. P.
E. P. …
BIOPORTAL: DOMAIN KNOWLEDGE
Cross-Referencing
06/13/2011 7
Basis on Developing Patent System Ontology Established semantics allow us to reason over the classes, properties and instances to infer new facts
Documents can be connected to form a network similar to citation networks. Only now we have not just citations, but other metadata such as co-inventorships, technological classification and other cross-domain relevancy metrics between documents (ex: patents occurring in court cases etc.)
Allows us to perform link analysis using algorithms such as Page Rank to establish importance
Can develop rules to perform additional inferences over the knowledge
06/13/2011 8
Single Domain• Return all patent documents which contain the keyword “erythropoietin” in the “claims”• Return all court cases which involve “Amgen_Inc” either as the plaintiff, defendant of both, and from the court “courtA”
Multi-domain:• Return all patents which contain the keyword – “erythropoietin” in the “claims”, which have been challenged in the courts
The complexity of the queries, depends on the user’s requirement
In general, the ontology should be able to answer:1. Textual queries2. Metadata queries, with numeric filters3. Multi-source queries
Competancy Questions
5/24/2011 9
Class Hierarchy - I
06/13/2011 10
Class Hierarchy - II
06/13/2011 11
Class Hierarchy - III
06/13/2011 12
Parsing the document to instantiate the Ontology
Case 1
Amgen ..
Chugai ..
hasPlaintiff
hasDefendant
Documents are automatically parsed using a regular expression based script
Separate scripts needed for each document domain
Ontology is automatically instantiated using the Protégé-OWL API
06/13/2011 13
Simple questions can be answered by currently existing systems
Return all Patents by the Inventor – “Fu-Kuen Lin” Return all Court Cases prior to yyyy-mm-dd Return all the patent documents which contain the keyword
“erythropoietin” in the Claims and Assigned to “Amgen_Inc”
The Patent System Ontology is intended to answer simple queries as well as complex queries which span more than a single information domain Return a court case which involves 3 or more patents From a file wrapper, identify the patents involved in an interference,
display information about the inventor, assignee, and claims of that patent. Further, enlist the other patents the inventor owns, if any.
Note: The patent system ontology allows inferring details about one document type (patents), based on the information from other document types (file wrappers)
What can you ask the Patent Ontology?
06/13/2011 14
Return all the patent documents which contain the keyword “erythropoietin” in the Claims and Assigned to “Amgen_Inc”. What technology classes do these patent documents belong to?
SPARQL Query:
Example Query
Patent Inventor
5856298Strickland_Thomas_
W5885574 Elliott_Steven_G7304150 Egrie_Joan_C7304150 Elliott_Steven_G7304150 Browne_Jeffrey_K7304150 Sitney_Karen_C7217689 Elliott_Steven_G7217689 Byrne_Thomas_E6319499 Elliott_Steven_G5756349 Lin_Fu-Kuen
SELECT DISTINCT ?patent ?inventorFROM <http://localhost:8890/PatentOntologyInferred>WHERE{ ?patent a ont:Patent .
?patent ont:hasAbstract ?abs .?abs ont:resourceVal ?val .?val bif:contains "erythropoietin" .
?patent ont:hasAssignee ont:Amgen_Inc .
?patent ont:hasInventor ?inventor
} Limit 10
06/13/2011 15
54 Classes, 40 Properties and over 15,000 individuals from 1150 patents, 30 court cases and one partially instantiated file wrapper
Used Protégé-OWL to edit the ontology and Protégé-OWL API to programmatically instantiate physical documents
Can query any SPARQL endpoint such as Protégé or Virtuoso’s Triple Store
Can also use SWRL to query (We haven’t developed SWRL query rules)
So Far …
06/13/2011 16
Use-Case: Erythropoietin
5 Core patents – U.S. Patents 5,621,080, 5,756,349, 5,955,422, 5,547,933, 5,618,698
135 directly related patents (through citations) form our gold standard for computing formal measures such as Precision and Recall
Total patent corpus of 1150 patents
Identified over related 3000 publications through citations. These are available on PubMed and can be accessed through Entrez – A tool that provides a search interface to PubMed database
Around 30 court cases, patent litigation involving major companies including Amgen, Hoechst Marion Roussel, Inc., Transkaryotic Therapies, Inc.
Current Corpus : experimental platform to test the overall effectiveness of the framework
06/13/2011 17
Querying BioPortal to Extract Concepts and Terms
06/13/2011 18
Original Term: Erythropoietin
Synonyms: Erythropoietin, Recombinant Erythropoietin, erythropoietin receptor binding, Hematopoietin, Recombinant EPO, Erythrocyte Colony Stimulating Factor, Epoetin, EPO …
Children: Darbopoietin Alfa, Epoetin Alfa, Epoetin Beta …
Parents: Colony Stimulating Factors, cytokine receptor binding, recombinant hematopoietic growth factors…
Grand-Parents: hematopoietic growth factor, receptor binding, recombinant growth factor …
An appropriate ranking function is to be applied to balance the more general terms. Heuristically, we assign a higher weight to synonyms, and a lower weight as we traverse away from the concept node
Resulting Query: “original term” OR [synonyms]^weight OR [children]^weight OR ….
Expanded Query
06/13/2011 19
1. Use bio-ontologies to expand user’s query, covering broader terms and concepts
2. Search document domain using expanded query3. Use patent system ontology’s properties to relate documents (from all
document domains)4. Support user feedback to ensure search progresses in right directions
Current prototype framework
Patent System Ontology
06/13/2011 20
Querying with SPARQL
06/13/2011 21
SELECT ?subject ?predicate ?objectWHERE {?subject ?predicate ?object }
VariablesOperation
Triples
SPARQL is a query language for RDF
Syntactically very similar to SQL – for relational databases
Any number of variables can be specified
Many triples can be used in conjunction to form more complex queries
We will use Virtuoso’s triple store to query the ontology
SELECT DISTINCT ?casesWHERE {
?cases a :CourtCase .?cases :hasBody ?caseBody .?caseBody :resourceVal ?
comment .
FILTER REGEX (?comment, "erythropoietin", "i") .
}
Court Cases with “Erythropoietin”
06/13/2011 22
Case_4: Amgen v/s Chugai …Case_5: Amgen v/s Genetics …Case_2: Amgen v/s Chugai …Case_3: Amgen v/s F. Hoffma…….
30 Cases retrieved
SELECT DISTINCT ?patentsWHERE {
?cases a :CourtCase .?cases :hasBody ?caseBody .?caseBody :resourceVal ?
comment .FILTER REGEX (?comment,
"erythropoietin", "i") .
?cases :patentsInvolved ?patents .}
Patents Involved in the Court Cases
06/13/2011 23
54118685621080: Production of Erythropoietin5547933: Production of Erythropoietin5618698: Production of Erythropoietin5756349: Production of Erythropoietin5955422: Production of Erythropoietin5441868470300846771955322837
Core Patents are in bold
SELECT DISTINCT ?docWHERE {
:FileWrapper_5955422 :contains ?doc .
?doc :hasDate ?date}ORDER BY ?date
List of Events in the File Wrapper
07_60974107_609741_Amendment_107_609741_Interference_107_609741_Rejection_107_957073_Amendment_1…P5955422 (Issued Patent)
06/13/2011 24
SELECT DISTINCT ?claimWHERE {
:07_609741 :hasClaim ?claim .}ORDER BY ?claim
Initial Claims of File Wrapper
07_609741_claim_107_609741_claim_207_609741_claim_3…07_609741_claim_60
A purified and isolated polypeptide having part or all of the primary structural conformation and one or more of the biological properties of naturally occurring erythropoietin and characterized by being the product of procaryotic or eucaryotic expression of an exogenous DNA sequence.
06/13/2011 25
SELECT DISTINCT ?claimWHERE {:07_609741_Interference_1 :InterferingClaims ?claimInt .:07_609741_Interference_1 :affectedClaims ?claim .
}ORDER BY ?claim
Summary of Interference RecordP4879272_claim_2P4879272_claim_3
An erythropoietin-containing, pharmaceutically-acceptable composition wherein human serum albumin is mixed with erythropoietin either during the preparation of said composition or just before administration thereof.
07_609741_claim_6007_609741_claim_6107_609741_claim_62
An erythropoietin-containing,pharmaceutically-acceptable preparation wherein human serumalbumin is mixed with erythropoietin.06/13/2011 26
One needs to know SPARQL in order to query
One needs to know the semantics of the ontology such as the relations, domain and range restrictions etc.
Performing manual querying can be very time consuming. Automation is needed
Domain specific semantics need to be separately integrated
Probabilistic weighing – ranking inventors, assignees, patents etc. is not possible using the SPARQL endpoint
We are developing a user-friendly automated tool to search the patent system
Current Limitations
06/13/2011 27
Include other information sources – publications, regulations, laws
Develop automated tool and search framework (Currently under development)
Experiment with more use cases outside of the biomedical domain
Future Work
06/13/2011 28
Tool Snapshot
06/13/2011 29
Acknowledgement
06/13/2011 30
This research is partially supported by NSF Grant Number 0811975 awarded to the University of Illinois at Urbana-Champaign and NSF Grant Number 0811460 to Stanford University. Any opinions and findings are those of the authors, and do not necessarily reflect the views of the National Science Foundation.
Please Visit the System
Demonstration
Thank You!Questions?
06/13/2011 31
Extra Slides
06/13/2011 32
SELECT DISTINCT ?inv ?class ?assigneeWHERE {
?cases a :CourtCase .?cases :hasBody ?caseBody .?caseBody :resourceVal ?comment .FILTER REGEX (?comment,
"erythropoietin", "i") .?cases :patentsInvolved ?patents .
?patents :hasInventor ?inv . ?patents :hasUSClass ?class . ?patents :hasAssignee ?assignee .
}
Common US Classes, Inventors and Assignee
06/13/2011 33
?invLin_Fu-KuenHewick_Rodney_MSeehra_Jasbir_S?classUSPC 530/380USPC 530/399USPC 530/397USPC 514/8USPC 435/69_6USPC 530/835USPC 530/388_7…
?assignee
Kirin-Amgen_IncGenetics_Institute_Inc…
34
SELECT DISTINCT ?forw ?backwWHERE {
?cases a :CourtCase .?cases :hasBody ?caseBody .?caseBody :resourceVal ?
comment .FILTER REGEX (?comment,
"erythropoietin", "i") .?cases :patentsInvolved ?patents .
?patents :hasCitation ?forw?backw :hasCitation ?patents .
}
Extracting Citations
06/13/2011
Results
6541033471047343585354558005446562447570064399216455800638658013033753
…
Generated Results
06/13/2011 35
Around 30 court cases
Several patents including core patents and forward/backward citations
Can search patents by the inventors, assignees and/or US class identified
What’s more? Can go search court cases with new keywords or information gathered
Gathered ResultsCase_4: Amgen v/s Chugai …Case_5: Amgen v/s Genetics In.Case_2: Amgen v/s Chugai …….5621080: Production of Erythropoietin5547933: Production of Erythropoietin5618698: Production of Erythropoietin5756349: Production of Erythropoietin5955422: Production of Erythropoietin… 5441868470300846771955322837…
Patents with Inventor: Lin_Fu-KuenPatents owned by Genetics_Inc…